Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TX › HOUSTON › SOUTH MAIN CLINIC, INC

SOUTH MAIN CLINIC, INC

NPI: 1326068933 · HOUSTON, TX 77035 · General Practice Physician · NPI assigned 07/20/2006

$824K
Total Medicaid Paid
44,416
Total Claims
36,110
Beneficiaries
59
Codes Billed
2019-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPINILLA, ALVARO (PRESIDENT OWNER)
NPI Enumeration Date07/20/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 195 $5K
2020 4,008 $82K
2021 10,519 $200K
2022 12,303 $206K
2023 9,308 $172K
2024 8,083 $160K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6,929 5,626 $258K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,858 2,539 $145K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,176 1,111 $108K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 732 713 $64K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,769 2,467 $41K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 901 808 $36K
90460 Immunization administration through 18 years of age via any route, first or only component 3,291 1,727 $33K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,393 1,089 $32K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,840 1,659 $24K
99000 1,985 1,763 $20K
81002 6,000 5,162 $17K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 925 788 $12K
99215 Prolong outpt/office vis 86 75 $6K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 71 64 $6K
92551 468 442 $4K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 57 55 $3K
93000 218 201 $2K
90461 263 210 $1K
76700 Ultrasound, abdominal, real time with image documentation; complete 13 13 $1K
92552 75 65 $1K
94060 38 30 $1K
97169 34 34 $1K
J2010 Injection, lincomycin hcl, up to 300 mg 64 58 $834.19
J0696 Injection, ceftriaxone sodium, per 250 mg 1,072 966 $821.09
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,634 1,469 $746.49
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 30 30 $723.62
92567 39 31 $451.07
94010 25 18 $441.33
87428 13 13 $375.69
90686 902 841 $310.39
97802 1,419 1,377 $302.50
81001 118 111 $296.43
G8510 Screening for depression is documented as negative, a follow-up plan is not required 73 71 $112.65
90621 89 82 $67.00
82570 14 12 $36.12
82947 16 14 $31.85
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg 65 42 $27.52
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 472 431 $19.29
J0690 Injection, cefazolin sodium, 500 mg 43 29 $13.17
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 1,443 1,373 $1.16
85025 Blood count; complete (CBC), automated, and automated differential WBC count 273 228 $0.72
80053 Comprehensive metabolic panel 235 202 $0.55
80061 Lipid panel 215 185 $0.51
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 188 151 $0.28
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 111 99 $0.24
82785 45 43 $0.11
90734 355 337 $0.10
80050 General health panel 78 68 $0.10
84439 12 12 $0.06
90658 32 32 $0.01
90651 59 59 $0.01
3725F 41 38 $0.00
90649 188 181 $0.00
99173 432 422 $0.00
90715 32 32 $0.00
86003 43 41 $0.00
96127 177 168 $0.00
36415 Collection of venous blood by venipuncture 117 89 $0.00
3008F 130 114 $0.00